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We have investigated transforming growth factor beta (TGF-)–mediated induction of actin stress fibers in normal and
metastatic epithelial cells. We found that stress fiber formation requires de novo protein synthesis, p38Mapk and Smad
signaling. We show that TGF- via Smad and p38Mapk up-regulates expression of actin-binding proteins including
high-molecular-weight tropomyosins, -actinin and calponin h2. We demonstrate that, among these proteins, tropomyo-
sins are both necessary and sufficient for TGF- induction of stress fibers. Silencing of tropomyosins with short
interfering RNAs (siRNAs) blocks stress fiber assembly, whereas ectopic expression of tropomyosins results in stress
fibers. Ectopic-expression and siRNA experiments show that Smads mediate induction of tropomyosins and stress fibers.
Interestingly, TGF- induction of stress fibers was not accompanied by changes in the levels of cofilin phosphorylation.
TGF- induction of tropomyosins and stress fibers are significantly inhibited by Ras-ERK signaling in metastatic breast
cancer cells. Inhibition of the Ras-ERK pathway restores TGF- induction of tropomyosins and stress fibers and thereby
reduces cell motility. These results suggest that induction of tropomyosins and stress fibers play an essential role in
TGF- control of cell motility, and the loss of this TGF- response is a critical step in the acquisition of metastatic
phenotype by tumor cells.
INTRODUCTION
There is solid evidence that the transforming growth factor
beta (TGF-) signaling pathway is a major cellular growth
inhibitory and proapoptotic pathway in epithelial, endothe-
lial, hematopoeitic, and other cell types (Roberts and Wake-
field, 2003). However, clinical and experimental studies in-
dicate that metastatic cancers of the breast and other tissues
express elevated levels of TGF- that appears to support the
metastatic behavior of the tumor cells (Saito et al., 2000;
Derynck et al., 2001). This apparent paradox has been asso-
ciated with a progressive decline in the antitumorigenic
function and a gain of protumorigenic activities of TGF-,
including induction of epithelial to mesenchymal transition
(EMT) and tumor cell migration and invasion (Derynck et al.,
2001; Wakefield and Roberts, 2002). Oncogenic Ras, Src, and
ErbB2 as well as alterations in TGF- signaling mediated by
Smads, mitogen-activated protein kinases (Mapks), Rho ki-
nases, and Akt/PKB are thought to contribute to the meta-
static phenotype (Derynck and Zhang, 2003; Roberts and
Wakefield, 2003).
The actin cytoskeleton plays a central role in the regula-
tion of cellular processes linked to metastasis including cell
proliferation, apoptosis, anchorage-independent cell
growth, and cell migration and invasion (Pawlak and Helf-
man, 2001; Jaffe and Hall, 2002). TGF- induces a rapid
reorganization of the actin cytoskeleton, leading to mem-
brane ruffling at the cell edges in both nontumorigenic and
tumorigenic epithelial cells, whereas a prolonged incubation
with TGF- results in the formation of stress fibers (Bakin et
al., 2002; Edlund et al., 2002). The immediate TGF-–medi-
ated changes in the actin cytoskeleton have been associated
with activation of the Rho family of GTPases, Rac, CDC42,
and RhoA (Bakin et al., 2002; Edlund et al., 2002), which
control cell motility and invasive phenotypes by regulating
organization of actin filaments (Jaffe and Hall, 2002). TGF-
regulates activity of these GTPases in various epithelial cell
lines independently of Smad signaling (Bhowmick et al.,
2001; Bakin et al., 2002; Edlund et al., 2002). The interplay
between Rho-like GTPases regulate both the protrusive and
contractile forces required for cell migration, via a combina-
tion of actin polymerization, depolymerization, and the in-
teraction of myosin-based motors with actin filaments (Eti-
enne-Manneville and Hall, 2002). Although RhoA
contributes to cell migration by inducing actomyosin con-
tractility, RhoA can also inhibit cell movement by stimulat-
ing the assembly of stress fibers and focal adhesions associ-
ated with the cell substratum (Cox et al., 2001). The TGF-
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induction of actin stress fibers has been shown to depend on
Smad signaling (Piek et al., 1999b), the RhoA-Rho kinase
pathway (Bhowmick et al., 2001), and p38Mapk signaling
(Hannigan et al., 1998; Bakin et al., 2002; Edlund et al., 2002).
However, the cellular targets regulated by these pathways
and their roles in TGF- regulation of stress fibers and cell
motility have not been defined.
Oncogenic transformation mediated by Ras and Src re-
sults in the disruption of actin stress fibers and focal adhe-
sions, whereas restoration of actin stress fibers inhibits cell
transformation and reduces metastasis (Pawlak and Helf-
man, 2001). The mechanisms mediating the disruption of
stress fibers by the Ras-ERK pathway involve inhibition of
the RhoA/ROCK pathway (Sahai et al., 2001; Pawlak and
Helfman, 2002a, 2002b; Vial et al., 2003) and repression of
actin-binding proteins involved in stabilization of actin fila-
ments including tropomyosins and -actinin (Pawlak and
Helfman, 2001). Thus, the Ras-Erk pathway may modify
TGF- regulation of stress fibers and cell motility through
one or both of these mechanisms.
In this study we demonstrate that expression of tropo-
myosins mediated by Smad and p38Mapk signaling is re-
quired for TGF- regulation of stress fibers and cell motility.
We show that the Ras-ERK pathway antagonizes TGF-
induction of stress fibers by suppressing expression of tro-
pomyosins. TGF- does not modulate cofilin phosphoryla-
tion, suggesting that the RhoA-ROCK-LIM kinase-cofilin
pathway is not rate limiting. We provide evidence that
tropomyosins are both necessary and sufficient for TGF-
induction of stress fibers. We show that expression of tro-
pomyosins in metastatic cells results in stress fibers and
reduces cell motility. These results suggest that loss of TGF-
–induced stress fibers is an essential characteristic of a
prometastatic conversion of TGF- function and that regu-
lation of tropomyosin expression is an important component
of this response.
MATERIALS AND METHODS
Antibodies, Plasmids, and Other Reagents
TGF-1 was obtained from R&D Systems (Minneapolis, MN). The following
antibodies were obtained from: to Smad2/3 (BD Transduction Laboratories, BD
Biosciences, Lexington, KY); rabbit polyclonal to hemaglutinin (HA) epitope
(Santa Cruz Biotechnology, Santa Cruz, CA); mouse monoclonal antibodies to
tropomyosin (TM311), -actinin, actin, and the Flag epitope (Sigma, St. Louis,
MO); to phospho-Smad2, phospho-ERK1/2, phospho-p38Mapk, phospho-ATF2,
phospho-HSP27, and HSP27 (Cell Signaling Technology, Beverly, MA). Phalloi-
din-Alexa Green and phalloidin-Texas Red were from Molecular Probes (Eugene,
OR). Fluorescein-labeled anti-HA antibody was from Roche Applied Science
(Indianapolis, IN). Plasmids encoding rat HA-tagged TM2 and TM3 isoforms
were described previously (Gimona et al., 1995). Inhibitors of p38Mapk
(SB202190, SB203580, PD165319), MEK1/2 (PD098059, U0126), JNK (SP600125),
Raf kinase, and protein synthesis (cycloheximide) were from Calbiochem (La-
Jolla, CA). Phospho-cofilin antibody was provided by Dr. James Bamburg,
Colorado State University (Fort Collins, CO).
Cell Culture
Mouse mammary epithelial NMuMG cells, human cervical carcinoma SiHa
cells, human breast cancer MDA-MB-231 cells, human epidermoid carcinoma
A431 cells, and human kidney HEK293T cells were purchased from American
Tissue Culture Collection (ATCC, Manassas, VA). Cells were cultured as
recommended by ATCC.
Adenoviral Infection of Cells
Adenoviruses encoding EGFP, Flag-tagged Smads, and the HA-tagged con-
stitutively active TGF- type I Alk5T204D receptor were produced using
HEK-293T cells and stored in aliquots at80°C. Cells grown on plastic dishes
or glass coverslips were incubated for 3 h with supernatant containing ad-
enoviruses at 5–10 MOI. Medium was replenished and cells were grown for
additional 24 h before further treatments.
RNA Isolation and cDNA Microarray Analysis
RNA from mouse nontumor mammary epithelial NMuMG cells treated with
2 ng/ml TGF-1 for 8 and 24 h was extracted as described in Bakin and
Curran, (1999). Total RNA from each sample (35 g) was labeled and hybrid-
ized with the NIA 15K Mouse array. Detailed descriptions of labeling and
hybridization procedures are available from http://array.mc.vanderbilt.edu/
Pages/Protocols/Protocols.htm. The array slides were scanned with an Axon
4000 scanner (Axon Instruments, Foster City, CA) at a resolution of 10 m.
The reference RNA from untreated NMuMG cells was labeled by using
cyanine 3-dUTP (Cy3), and the RNA samples from TGF1-treated cells were
labeled with cyanine 5-dUTP (Cy5). This experiment was performed in trip-
licate. Data were analyzed using GenePix4.0 software.
Immunoblot Analysis
Cells were incubated in medium containing 5% serum for 24 h before treat-
ment with 2 ng/ml TGF-1. Cells were lysed in buffer containing 20 mM Tris,
pH 7.4, 137 mM NaCl, 1% NP-40, 10% glycerol, 20 mM NaF, 1 mM Na
orthovanadate, 1 mM PMSF, 2 g/ml aprotinin, and 2 g/ml leupeptin.
Immunoblot analyses of protein extracts were performed as described (Bakin
et al., 2002).
Northern Blot and Reverse Transcription-Polymerase
Chain Reaction Analysis
A cDNA fragment of rat TM3 and a polymerase chain reaction (PCR)-
generated fragment of -actinin1 cDNA spotted on the microarrays (GenBank
accession number BG077689) were used as probes for Northern blot analysis.
Identity of -actinin1 and calponin2 cDNAs were verified by DNA sequenc-
ing matched through BLAST analysis (www.ncbi.nlm.nih/BLAST/). Total
RNA samples (15 g/lane) obtained from NMuMG cells treated with 2 ng/ml
TGF-1 for 4, 8, and 24 h were subjected to Northern blot analysis as
described previously (Bakin and Curran, 1999). Amplification of transcripts
was performed using 50 ng/L of total RNA and one-step reverse transcrip-
tion (RT)-PCR system from Invitrogen (Carlsbad, CA) according to the man-
ufacturing protocol. Primer sequences: -actin, accession no. NM_007393,
forward: GCTGGTCGTCGACAACGGCTC, reverse: CAAACATGATCT-
GGGTCATCTTTTC; -tropomyosin, accession no. NM_024427.2, forward:
GCTGGTGTCACTGCAAAAGA, reverse: CCTGAGCCTCCAGTGACTTC;
-tropomyosin, accession no. NM_009416.2, forward: AAGGATGCCCAG-
GAGAAACT, reverse: CTTCCTTCAGCTGCATCTCC; calponin2, accession
no. NM_007725.1, forward: ACCCTGTGGACCTGTTTGAG, reverse: TG-
GAAGAGTTGTCGCACTTG; PAI-1, accession no. M33960.1, forward:
CCACCGACTTCGGAGTAAAA, reverse: GCGTGTCAGCTCGTCTACAG.
Immunofluorescence Microscopy
Cells (105cells/well) were grown in DMEM containing 5% fetal bovine serum
(FBS) on glass coverslips (22 22 mm) for 24 h before treatment with 2 ng/ml
TGF-1. Cells were fixed with 4% paraformaldehyde and stained as described
(Bakin et al., 2002). Actin filaments (F-actin) were stained with phalloidin-
Alexa Green or phalloidin-Texas Red, and tropomyosins were visualized
using TM311 antibody. Fluorescent images were captured using Zeiss Axio-
phot upright microscope (Thornwood, NY) and Nikon TE2000-E inverted
microscope (Garden City, NY). In some experiments cells were permeabilized
with 0.05% Triton X-100 for 10 min followed by fixation and staining.
Wound Closure Assay
The assay was performed as described previously (Bakin et al., 2002). MDA-
MB-231 cells (1–2  105/well) were seeded in 12-well plates and incubated in
serum-free IMEM (Invitrogen) medium for 24 h before wounding with plastic
tip across the cell monolayer. Kinase inhibitors were added 1 h before wound-
ing. The cells were left untreated or treated with 2 ng/ml TGF-1 for 16 h. The
wound closure was estimated as the ratio of the remaining wounded area
relative to the initial area. Experiments were repeated at least three times.
Transcriptional Assay
NMuMG cells (3  104) were seeded in 24-well plates and transfected with
0.16 g/ml pSBE-Lux containing 12 repeats of Smad binding sequence (pro-
vided by J.-M. Gauthier, Laboratoire Glaxo Wellcome, Les Ulis Cedex, France)
with 0.002 g/ml pCMV-Rl (Promega, Madison, WI) using FuGENE6 reagent
(Roche Molecular Biochemicals, Indianapolis, IN) according to the manufac-
turer’s protocol. Cells were incubated for 8 h in 0.5% FBS-DMEM before
treatment with 1 ng/ml TGF-1 for 16 h. Firefly luciferase (Luc) and Renilla
reniformis luciferase (Rl) activities in cell lysates were determined using the
Dual Luciferase Reporter Assay System (Promega) according to the manu-
facturer’s protocol in a Monolight 2010 luminometer (Analytical Lumines-
cence Laboratory, San Diego, CA). Luc activity was normalized to Rl activity
and presented as Relative Luciferase Units. All assays were done in triplicate
wells and each experiment was repeated at least twice.
Tropomyosins in TGF-–induced Stress Fibers
Vol. 15, October 2004 4683
Short Interference RNA Studies
RNA duplexes against human (cat. no. M-003902) and mouse (cat. no.
M-004199) Smad4 were obtained from Dharmacon Research, Inc. (Lafayette,
CO). RNA duplexes against tropomyosin (target sequence: AAGCAGCTG-
GAAGATGAGC) were designed using the siDESIGN program at the Dhar-
macon siDESIGN center. A scramble control RNA duplex labeled with rhoda-
mine was obtained from Qiagen (Chatsworth, CA). Cells were transfected
with RNA duplexes using Oligofectamine reagents (Invitrogen) following the
manufacturers protocol. The cells were transferred onto glass coverslips or
plastic dishes. Forty-eight hours posttransfection, the cells were treated with
TGF-1 for 24 h followed by immunoblot and immunofluorescence analysis.
RESULTS
TGF-–induced Actin Stress Fiber Formation in Epithelial
Cells Requires De Novo Protein Synthesis and p38Mapk
The mechanism of TGF-–induced stress fiber (SF) forma-
tion was characterized in NMuMG mouse mammary epi-
thelial cells. These cells exhibit a cuboidal cell morphology
and a cortical organization of actin filaments in adhesion
belts. Treatment of the cells with TGF-1 for 24 h induced
formation of actin microfilament bundles (Figure 1). Actin
filaments in adhesion belts were not significantly affected in
the first 4 h of TGF- treatment compared with untreated
cells (Figure 1a), and SFs were not observed until 8 h after
TGF- addition. SFs were well developed in cells incubated
with TGF- for 24 h. This TGF- response was blocked by
treatment of cells with the p38Mapk inhibitor, SB202190,
suggesting involvement of p38Mapk in TGF-–regulated
SFs. This inhibitor did not significantly affect phosphoryla-
tion of Smad2 and TGF-–mediated activation of the Smad-
dependent luciferase reporter activity (Figure 1, b and c).
Similar results were also obtained with two other p38Mapk
inhibitors (SB203580 and PD165319; our unpublished re-
sults). Treatment of cells with the JNK inhibitor, SP600125,
did not block TGF-–mediated SF formation (Figure 1a),
although it effectively blocked phosphorylation of ATF2
(Figure 1e). Expression of kinase-inactive mutant of mito-
gen-activated protein kinase kinase 6 (MKK6) blocked phos-
phorylation of p38Mapk and SF formation (Bakin et al., 2000,
2002). In previous studies we have shown that TGF- does
not activate the ERK pathway in NMuMG cells and inhibi-
tion of MEK1/2 does not block stress fiber formation. Sim-
ilar results were obtained for human cervical carcinoma
SiHa cells, in which TGF- induces p38Mapk signaling and
SFs (Bakin et al., 2002). To investigate whether this process
depends on de novo protein synthesis, cells were treated
with cycloheximide, the protein synthesis inhibitor. Cyclo-
heximide blocked SF formation when added as late as 6 h
after initiation of TGF- treatment without inhibition of
p38Mapk activation (Figure 1, a and d), but it had no effect
after 12 h (our unpublished results). Thus, de novo protein
synthesis and p38Mapk activity are required for TGF-–
mediated actin SF formation in epithelial cells.
Figure 1. TGF-1–induced actin stress fibers
require p38Mapk and a novel protein synthe-
sis. (a) Actin filaments staining with phalloi-
din-Alexa Green in cells treated with 2 ng/ml
TGF-1 in the absence or presence of inhibi-
tors. Where it is indicated, cells were treated
with 10 g/ml cycloheximide (CHX) starting
at 6 h after addition of TGF-1. Kinase inhib-
itors (15 M SP600125, a JNK inhibitor, and 10
M SB202190, a p38Mapk inhibitor) were
added 1 h before addition of TGF1. Scale
bar, 15 m. (b) Luciferase activity in NMuMG
transfected with Smad-dependent reporter
pSBE-Lux and pCMV-Rl vectors and treated
with 1 ng/ml TGF-1 for 16 h in the absence
or presence of 15 M SB202190. Each bar rep-
resents the mean  SD of three wells. P value
was determined by t test. The difference in
luciferase activity in control and SB202190-
treated cells is not statistically significant. (c)
Immunoblot analysis of Smad2 phosphoryla-
tion in protein extracts (35 g/well) from
NMuMG cells treated with 2 ng/ml TGF-1
in the absence or presence of 10 M SB202190.
(d) p38Mapk phosphorylation in response to
TGF-1 in protein extracts (35 g/well) from
SiHa cells cotreated with 10 g/ml cyclohex-
imide (CHX). (e) Inhibition of ATF2 phos-
phorylation by JNK inhibitors in protein ex-
tracts (35 g/well) from NMuMG cells
treated with 2 ng/ml TGF-1.
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TGF- Up-regulates Expression of Genes Encoding Actin-
binding Proteins
To identify TGF- target genes that mediate actin remod-
eling, we compared gene expression profiles in NMuMG
cells before and after treatment with TGF-1 for 24 h
using mouse cDNA microarrays. The results indicate that
expression of 62 genes changed more than twofold after
treatment with TGF-1. Among these genes TGF- stim-
ulated expression of several genes encoding actin-binding
proteins including tropomyosins (TM), -actinin1, and
calponin2 (Table 1). These proteins are known to be in-
volved in the assembly of stable actin microfilament bun-
dles (Ayscough, 1998; Danninger and Gimona, 2000;
Tseng et al., 2002; Hossain et al., 2003). The -tropomyosin
and -tropomyosin genes encoding high-molecular-
weight tropomyosins were up-regulated 2–2.6-fold and
were represented by two and three cDNA clones, respec-
tively. Interestingly, Tpm3 and Tpm4 genes encoding
low-molecular-weight tropomyosins were not regulated
by TGF- (Table 1).
Treatment with a p38Mapk inhibitor suppressed induc-
tion of tropomyosins by 30 – 45% without a significant
effect on calponin2 (Table 1). Northern blot analysis with
rat TM3 cDNA, a product of the -TM gene, revealed a
1.6-fold increase in the TM mRNA levels at 4 h reaching a
3.6-fold induction at 24 h of TGF-1 treatment (Figure 2a).
Similar regulation was observed for -actinin (Figure 2a).
Cotreatment with a p38Mapk inhibitor reduced by 35%
the induction of -TM mRNA, without a significant effect
on -actinin1 (Figure 2a), suggesting that p38Mapk is
involved in tropomyosin gene expression. Using RT-PCR
we confirmed TGF-–mediated regulation of calponin2
and that PAI-1, a known TGF--target gene, is regulated
with kinetics similar to the newly identified TGF- target
genes (Figure 2b). The regulation of highly conserved
-TM and -TM genes was further confirmed using RT-
PCR with isoform specific primers (Figure 2c), because
tropomyosin sequences are conserved. The specificity was
also confirmed using cDNA clones for TM1, TM2, and
Figure 2. TGF- regulates expression of genes
encoding actin-binding proteins in NMuMG
cells. (a) Northern blot analysis of TM2/3 and
-actinin1 mRNA levels in total RNA samples (15
g/lane) from NMuMG cells treated with 2
ng/ml TGF-1 in the absence or presence of 10
M SB202190. Blots were quantified using Phos-
phorImager. Bottom panel shows ethidium bro-
mide staining of total RNA. (b–e) Analysis of
-actin, PAI-1, calponin2, and - and -tropomy-
osin transcripts by PCR with reverse transcription
in total RNA samples from NMuMG cells treated
with 2 ng/ml TGF-1. Where it is indicated, cells
were treated with 10 g/ml cycloheximide
(CHX) 1 h before addition of TGF-1.
Table 1. Regulation of genes encoding actin-binding proteins by
TGF-1 in NMuMG cells
Fold Change SE
Gene
Accession
no. of cDNA
clones TGF-1
TGF-1
SB202190
1 Actn1 BG077689 3.03  0.66 2.20  0.18
2 Actn1 BG065930 2.94  0.48 2.37  0.48
3 -Tropomyosin BG086016 1.81  0.39 1.48  0.09
4 -Ttropomyosin BG079039 2.15  0.57 1.30  0.04
5 -Tropomyosin BG076419 2.48  0.09 1.52  0.20
6 -Tropomyosin BG073088 2.37  0.36 1.37  0.36
7 -Tropomyosin BG087093 2.83  0.43 1.83  0.48
8 Tpm3 BG077822 1.28  0.12 1.38  0.19
9 Tpm3 BG078017 1.22  0.08 1.40  0.08
10 Tpm3 BG064681 1.28  0.07 1.40  0.08
11 Tpm3 BC029186 1.16  0.15 0.91  0.11
12 Tpm4 BG077934 0.96  0.11 0.90  0.18
13 Tpm4 AW537534 1.34  0.12 1.46  0.22
14 Cnn2 (H2) BG079442 3.00  0.25 3.11  0.29
cDNA microarray analysis was performed using total RNA from
NMuMG cells, which were untreated or treated with 2 ng/ml
TGF-1 for 24 h in the absence or presence of 10 M SB202190. The
data represent an average of three independent experiments.
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TM3 (our unpublished results). Examination of - and -TM
mRNA levels in the cells cotreated with cycloheximide showed
that TGF- induction of these genes was not affected by cyclo-
heximide, indicating that these genes are directly regulated by
the TGF- signaling pathway (Figure 2, d and e). Thus, we
have identified tropomyosins -actinin1 and calponin2 as
novel TGF- target genes that may account for TGF- regula-
tion of actin filament dynamics.
TGF- Up-regulates Expression of Tropomyosins and
Induces Phosphorylation of HSP27 in Epithelial Cells
In vertebrates, more than 10 different isoforms of high-
molecular-weight tropomyosins are expressed from - and
-TM genes and by alternative RNA splicing (Pittenger et al.,
1994). Tropomyosins form -helical coil-coil dimers that
bind along the length of the actin filaments interacting with
6–7 actin monomers are thought to be essential for the
assembly and stabilization of actin filaments. (Ayscough,
1998). In this study we used the TM311 mAb recognizing
tropomyosin 1 (TM1), a product of the -TM gene, and
tropomyosin isoforms 2, 3, and 6 (TM2,3,6), products of the
-TM gene (Temm-Grove et al., 1998). Immunoblot analysis
with TM311 antibody followed by reblotting with anti--
actin mAb showed that TGF- induced a 4.8-fold increase in
TM2 and TM3 in NMuMG cells (Figure 3a). Induction of
TM1 and TM6 was also detected but required longer film
exposures (Figure 3a, insert), suggesting that TM2 and TM3
are the main tropomyosin isoforms regulated by TGF- at
the protein level in NMuMG cells. The difference in the
regulation of protein and mRNA levels of TM1 in response
to TGF-1 is not obvious and may be related to a tight
regulation of / tropomyosin isoforms (Robbins, 1998).
Analysis of Smad2 and p38Mapk phosphorylation in the
same cells showed activation of Smad and p38 signaling at
30 min and a sustained level for at least 24 h (Figure 3a).
Inhibition of p38Mapk significantly reduced the induction of
tropomyosins without affecting basal level expression (Fig-
ure 3b), suggesting a more profound effect of p38Mapk on
tropomyosin protein than on mRNA (see Figure 2a). Inhibi-
tion of p38Mapk did not block phosphorylation of Smad2
Figure 3. TGF- regulates tropomyosins
and HSP27 phosphorylation in epithelial
cells. (a and b) Immunoblot analysis of actin
and tropomyosins as well as phosphorylation
of Smad2, HSP27, and cofilin using phospho-
specific antibodies in NMuMG cells treated
with 2 ng/ml TGF-1. Where it is indicated 10
M SB202190 was added 1 h before TGF-
treatment. Inset shows induction of TM1 and
TM6 on a longer exposed film of the same
immunoblot. (c–f) Immunoblot analysis of
tropomyosin expression and phosphorylation
of Smad2, p38Mapk, and cofilin in SiHa cells
treated with 2 ng/ml TGF-1. Where it is
indicated, the cells were cotreated 1 h before
addition of TGF- with 10 M SB202190 (SB),
5 M U0126 (U), or 15 M SP600125 (SP).
Insert shows immunoblot with TM311 anti-
body using the same protein extracts as in c.
Fold difference of tropomyosin levels relative
to actin was estimated using NIH ImageJ soft-
ware (http://rsb.info.nih.gov/nih-image/).
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and Smad-dependent transcription (Figure 1, b and c) and
did not affect expression of calponin2 (Table 1).
TGF- also mediated up-regulation of TMs and p38Mapk
signaling in human cervical carcinoma SiHa cells (Figure 3,
c–f), which respond to TGF- with SFs (Bakin et al., 2002).
TGF- stimulated a nearly twofold increase in TM1 and a
ninefold increase in TM2/3 levels (Figure 3c). A comparable
TGF-–mediated induction of TMs and stress fiber formation
were also observed in A549 lung epithelial cells (our unpub-
lished results). SiHa cells express relatively low basal levels of
TM2/3/6, but a high basal level of TM1 (Figure 3c). p38Mapk
inhibitors blocked this up-regulation of TM2/3 (Figure 3, c and
e), whereas inhibitors of MEK1/2 (U0126) and JNK, SP600125,
did not (Figure 3e). Induction of the -TM gene in SiHa cells at
the mRNA level was confirmed by RT-PCR (see Figure 8a). We
found that the activation of the Smad pathway and Smad3
levels were noticeably lower in SiHa cells (Figure 3d) than in
NMuMG cells (Figure 3a). This may explain the moderate
regulation of tropomyosins in SiHa cells compared with
NMuMG cells and support the notion that Smads are involved
in TGF-–mediated regulation of tropomyosins.
The small heat shock protein HSP27 is a downstream target of
p38Mapk signaling (Huot et al., 1998). The HSP27 phosphoryla-
tion by p38Mapk-MAPKAP2/3 signaling at three serine residues
increases a pool of HSP27 tetramers that facilitate actin polymer-
ization (Huot et al., 1998; Hedges et al., 1999; Rogalla et al., 1999).
Using phospho-HSP27 antibodies we found that TGF- stimu-
lates a sustained phosphorylation of HSP27 in SiHa cells (Figure
3d). This is blocked by the p38Mapk inhibitor (Figure 3f). The
actin filament dynamics is also controlled by the RhoA/ROCK/
LIM-kinase pathway that regulates actin depolymerizing activity
of ADF/cofilin by phosphorylation of a conserved serine3 in
ADF/cofilin (Bamburg, 1999). Examination of cofilin phosphory-
lation in NMuMG (Figure 3a) and SiHa cells (Figure 3d) with
phospho-Ser3–specific antibodies showed that levels of cofilin
phosphorylation did not change in response to TGF- during
stress fiber formation. These results indicate that TGF- induction
of stress fiber formation in epithelial cells is accompanied with an
increase in expression of actin-binding proteins and p38Mapk-
HSP27 signaling without a significant regulation of the ROCK/
LIM-kinase/cofilin pathway.
The Smad Signaling Pathway Mediates Regulation of
Tropomyosin Expression by TGF-
To examine the involvement of Smads in TGF-–induced
expression of tropomyosins and SFs, we transfected
NMuMG and SiHa cells with short interfering RNA du-
plexes (siRNA) against Smad4. Transfection of siRNAs sig-
nificantly reduced Smad4 protein levels and TGF-–induced
expression of TM2/3 in NMuMG (Figure 4a). A more effec-
tive action of siRNAs was observed in SiHa cells where
TM2/3 expression was prevented and TM1 level was re-
duced by 40–55% (Figure 4b). Staining of actin filaments
with phalloidin-Alexa Green demonstrated a significant re-
duction in TGF-–induced SFs in both cells lines transfected
with siRNAs to Smad4 (Figure 4, c and d, panels C and D),
compared with control siRNA (Figure 4, c and d, panels A
and B). These results support a model that Smad signaling
mediate induction of tropomyosin expression in response to
TGF leading to formation of SFs in epithelial cells.
To test the contribution of specific Smads in the regulation
of TMs and SFs, we used adenovirus-mediated expression of
cDNAs encoding individual Smads in SiHa cells. These cells
express low levels of Smad3 and Smad4 compared with
NMuMG cells (Figure 3, a and d; Lee et al., 2001). Flag-
tagged Smad2 and Smad3 were expressed at comparable
levels in SiHa cells infected with Smad-encoding adenovi-
ruses (Figure 5, a and b). Smad3 significantly increased
TGF-–induced expression of tropomyosins compared with
Figure 4. Smad signaling is required for
TGF-–induced expression of tropomyosins
and stress fiber formation in epithelial cells.
(a and b) Immunoblot analysis of tropomyo-
sins and Smad4 in NMuMG cells (a) and
SiHa cells (b) transfected with siRNAs
against Smad4. (c and d) Actin filament
staining with phalloidin-Alexa Green in
NMuMG and SiHa cells transfected with
control scramble siRNA (A and B) or siR-
NAs to Smad4 (C and D). The cells were
treated with 2 ng/ml TGF-1 for 24 h. Scale
bar, 10 m. Fold differences in tropomyosin
and Smad4 levels relative to -catenin were
estimated using NIH ImageJ software.
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control EGFP-encoding adenovirus, whereas Smad2 exhibited
only a moderate effect (Figure 5a). Coinfection with adenovi-
ruses encoding Smad3 and Smad4 resulted in a marked in-
crease of TMs even in the absence of added cytokine (Figure
5b), suggesting that Smad3 and Smad4 mediate TGF-–regu-
lated expression of tropomyosins. We next examined tropomy-
osin regulation by Smad7, an inhibitor of TGF- signaling
mediated by Smad2 and Smad3 (Massague, 1998). Expression
of Smad7 inhibited TGF-–induced expression of TM2/3 (Fig-
ure 5b) and phosphorylation of Smad2 (Figure 5c), whereas
Smad6, an antagonist of bone morphogenic protein (BMP)
signaling, had no effect (our unpublished results). In parallel,
we examined actin filaments in SiHa cells infected with the
adenoviral constructs (Figure 5d). As predicted, Smads that
mediated enhancement of TM expression also increased SFs.
Coexpression of Smad3 and Smad4 markedly increased SFs in
the absence of exogenous TGF-, which were further enhanced
by the cytokine suggesting that other signaling events may also
be involved in the assembly of stress fibers. Coexpression of
constitutively active TGF- type I receptor, Alk5T204D, and
Smad3 resulted in SFs independent of exogenous TGF-. Fi-
nally, expression of Smad7 significantly inhibited TGF-–in-
duced SF assembly (Figure 5e). These results demonstrate that
Smad3 and Smad4 mediate TGF-–induced expression of tro-
pomyosins and SF formation.
Tropomyosins Are Required for SF Formation in Response
to TGF-
We confirmed that tropomyosins are localized with stable actin
filaments resistant to Triton treatment. SiHa cells treated with
TGF- for 24 h were first incubated with Triton X-100 and then
fixed with 4% paraformaldehyde. Actin filaments were detected
with phalloidin and tropomyosins with the TM311 antibody. Im-
munofluorescence microscopy showed that tropomyosins were
localized along the actin microfilaments in a periodical pattern
(Figure 6a).
To examine whether tropomyosins are required for TGF-–
mediated SF formation, SiHa cells were transfected with siRNA
duplexes against tropomyosins (si-TMs) or a scrambled siRNA
control. si-TMs effectively suppressed basal and TGF-–induced
expression of tropomyosins (Figure 6b). TGF- induced SFs in
cells transfected with a scrambled siRNA control (Figure 6c, pan-
els A and B), whereas SFs were significantly reduced by si-TMs
(Figure 6c, panels E and F). In control cells, TGF- induced elon-
gation of cells and localization of tropomyosins to actin filaments,
whereas in the si-TM cells this response was significantly reduced
(Figure 6c, panels C and D and G and H). A complementary
experiment tested the gain-of-function by transfection of
NMuMG and SiHa cells with expression vector for rat HA-tagged
TM3. Expression of TM3 alone, without TGF- treatment, was
sufficient to induce SFs in both cell lines similar to cells treated
with TGF-1 (Figure 6d, red, panels C and D). Staining with
fluorescein-labeled anti-HA antibody showed colocalization of
HA-tagged TM3 with actin filaments (Figure 6d, panels A and B,
and overlay). These results indicate that tropomyosins are both
necessary and sufficient for TGF-–induced stress fiber formation.
TGF- Does Not Induce Stress Fibers but Stimulates Cell
Migration in Metastatic Cells
Actin filaments are dynamic structures and stabilization of
actin filaments limits cell movement. TGF- induces stress
fibers in NMuMG and SiHa cells and cells from both lines
Figure 5. Smads mediate TGF-–induced tro-
pomyosin expression and stress fiber forma-
tion. (a and b) Tropomyosin expression in cells
infected with adenoviruses encoding EGFP
(GFP) and Flag-tagged Smad2, Smad3, Smad4,
and Smad7. Cells were treated with 2 ng/ml
TGF-1 for 24 h. (c) Inhibition of TGF-1–in-
duced phosphorylation of Smad2 by adenoviral
expression of Smad7 in SiHa cells. (d) Actin
filaments staining in SiHa cells infected with
adenoviruses: EGFP, Smad3, Smad4, Smad7,
constitutively active Alk5T204D, or their com-
binations. The cells were treated with 2 ng/ml
TGF-1 for 24 h. Scale bars, 15 m.
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Figure 6. Tropomyosins are required for TGF-–induced stress fiber formation. (a) Localization of tropomyosins (TM) to stable actin
filaments (actin) resistant to 0.05% Triton X-100 treatment in SiHa cells untreated or treated with TGF-1 for 24 h. Scale bar, 10 M. (b)
Suppression of tropomyosin expression in SiHa cells transfected with siRNA against TMs (si-TM) compared with a scrambled control. (c)
Actin filaments (A, B, E, and F) and tropomyosin (C, D, G, and H) in SiHa cells, transfected with siRNA against tropomyosins (E–H) and a
scrambled control siRNA (A–D). The cells were treated with 2 ng/ml TGF-1 for 24 h. Scale bar, 10 M. (d) Actin filaments in NMuMG and
SiHa cells expressing HA-tagged TM3. Cells were stained with phalloidin-Texas Red and fluorescein-labeled anti-HA antibody (A–F).
Overlay images are shown in panels E and F. Panels G and H show actin filaments and tropomyosins (TM311 antibody) in cells transfected
with empty vector control. Scale bar, 15 m.
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fail to migrate in response to TGF- in a wound closure
assay (our unpublished results). TGF- has been shown to
stimulate migration of metastatic breast cancer MDA-MB-
231 cells in wound closure assay (Bakin et al., 2002). We
hypothesized that TGF-–mediated stress fiber response is
altered in MDA-MB-231 cells. Accordingly, treatment of
MDA-MB-231 cells with TGF- did not result in the forma-
tion of stress fibers (Figure 7a). MDA-MB-231 cells express
TGF- receptors, Smad factors, and respond to TGF-1 with
activation of Smad, p38Mapk signaling, and regulation of
gene expression (Bakin et al., 2002; Dumont et al., 2003 and
Figure 7c). It has been reported that MDA-MB-231 cells have
constitutively active Ras-ERK signaling (Kozma et al., 1987;
Ogata et al., 2001), which may through the repression of the
ROCK/LIM-kinase/cofilin pathway affect SF formation (Sa-
hai et al., 2001; Pawlak and Helfman, 2002b). Thus, we
examined phosphorylation of cofilin, a target of LIM kinase,
in MDA-MB-231 cells. The immunoblot showed a rela-
tively high basal level of the cofilin phosphorylation that
was not modulated by TGF-. Treatment of these cells
with the MEK inhibitor did not affect the basal cofilin
phosphorylation but blocked phosphorylation of ERK1/2
(Figure 7b). However, MEK inhibition significantly en-
hanced TGF-–induced stress fiber formation (Figure 7d)
and blocked TGF-–mediated cell migration (Figure 7e).
The TGF- regulation of stress fibers was also restored by
MEK inhibitor PD098059 and by inhibition of Raf kinase
(our unpublished results). These results suggest that the
ERK pathway suppresses TGF-–mediated stress fiber
formation in epithelial cells through a mechanism medi-
Figure 7. TGF- and ERK signaling differentially regulate stress fiber formation. (a) Actin filaments staining in MDA-MB-231 cells treated
with TGF-1 for 24 h. (B) Phosphorylation of cofilin and ERK1/2 in MDA-MB-231 cells cotreated with TGF-1 for 24 h and 5 M U0126. (c)
Immunoblot analysis of p38Mapk phosphorylation in MDA-MB-231 cells treated with 2 ng/ml TGF-1. (d) Actin filaments staining in
MDA-MB-231 cells cotreated with TGF-1 and 5 M U0126 for 24 h. (e) Wound closure in MDA-MB-231 cells treated with TGF-1 in the
absence or presence of 5 M U0126. The experiment was done in triplicates and repeated at least two times. Scale bar, 20 M.
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ated by a pathway other than the ROCK/LIM-kinase/
cofilin pathway.
Suppression of TGF-–regulated Tropomyosin Expression
by Ras-ERK Signaling in Metastatic MDA-MB-231 Cells
The Ras-ERK pathway has been implicated in suppression
of tropomyosins and disruption of the actin cytoskeleton
(Ljungdahl et al., 1998; Shields et al., 2002). We next exam-
ined whether the inability of TGF- to induce stress fibers in
MDA-MB-231 cells is associated with alteration of tropomy-
osin expression or function by Ras-ERK signaling. We com-
pared expression of tropomyosins in MDA-MB-231 cells and
SiHa cells, which show a low basal level of ERK phosphor-
ylation. RT-PCR and immunoblot analysis showed that
MDA-MB-231 cells express significantly less of TM1 mRNA
and protein and undetectable levels of TM2/3 in compari-
son to SiHa cells (Figure 8, a and b). Treatment of MDA-
MB-231 cells with the MEK inhibitor U0126 reduced ERK
phosphorylation (Figure 7b), increased TGF-–induced ex-
pression of TM1 (Figure 8c), and restored stress fibers (Fig-
ure 7d). Similar results were obtained with a Raf kinase
inhibitor (our unpublished results). These data suggest that
Raf-ERK signaling down-regulates a basal and TGF-–reg-
ulated expression of tropomyosin. Our findings also indicate
that the -tropomyosin gene is silenced in MDA-MB-231
cells.
We next examined whether ectopic expression of TM3, a prod-
uct of the -tropomyosin gene, will affect SFs and cell migration.
MDA-MB-231 cells were transfected with expression vector en-
coding rat HA-tagged TM3 (Figure 8d) and analyzed for changes
in cell morphology and actin filament assembly. Phase contrast
images showed that TM3 expressing cells have a significant in-
crease in cell size and a flatter more well-spread morphology
compared with the refractile appearance of the parental cells or
the control cells transfected with an empty vector (Figure 8e).
Expression of TM3 markedly increased SFs in MDA-MB231 (Fig-
ure 8f) and inhibited cell motility assessed in the wound closure
assay (our unpublished results). Interestingly, ectopic expression
of either TM3 or TM2 inhibited proliferation of MDA-MB-231
cells increasing a number of multinucleated cells. We are currently
developing inducible model to study effect of TMs on motility and
growth of MDA-MB-231 cells. It has been also reported that
overexpression of TM1 in MDA-MB-231 cells inhibits growth and
motility of MDA-MB-231 cells (Raval et al., 2003). Thus, overex-
Figure 8. TGF- and ERK signaling differentially regulates expression of tropomyosins. (a) Analysis of -TM and -TM transcripts by RT-PCR
in total RNA samples from MDA-MB-231 (MDA) and SiHa cells treated with 2 ng/ml TGF-1 for 24h. (b) Immunoblot analysis of tropomyosin
expression in protein extracts (35 g/lane) from SiHa and MDA-MB-231 cells treated with 2 ng/ml TGF-1. (c) Tropomyosin protein expression
in MDA-MB-231 cells cotreated with TGF-1 and 5 M U0126 for 24h. (d) Detection of HA-tagged rat TM3 with anti-HA antiserum in protein
extracts from two independent transfections of MDA-MB-231 cells with expression vector encoding HA-tagged rat TM3 (T1 and T2) or a control
empty vector (C1 and C2). (e) Phase-contrast images show flattening and size increase in TM3-transfected MDA-MB-231 cells compared with
control cells. (f) Immunofluorescence images show a marked increase in actin stress fibers in TM3-transfected MDA-MB-231 cells. Scale bar, 20 M.
Fold differences in tropomyosin levels relative to actin were estimated using NIH ImageJ software.
Tropomyosins in TGF-–induced Stress Fibers
Vol. 15, October 2004 4691
pression of tropomyosins in metastatic MDA-MB-231 cells results
in stress fibers and reduces cell motility. Collectively, the data
presented above demonstrate that the Ras-ERK pathway inhibits
TGF- induction of stress fibers by suppressing expression of
tropomyosins.
DISCUSSION
The molecular mechanism(s) underlying the prometastatic
conversion of the TGF- function is a major focus of current
investigation by many research groups (reviewed in
Derynck and Zhang, 2003; Roberts and Wakefield, 2003). In
this study we found that the ability of TGF- to induce stress
fibers and, therefore, to control cell migration is significantly
compromised in metastatic breast carcinoma cells. We pro-
vide evidence that tropomyosins are critical cellular compo-
nents of Smad/p38Mapk-dependent actin stress fiber as-
sembly in response to TGF- in epithelial cells. We further
show that the Ras-ERK pathway antagonizes TGF- induc-
tion of tropomyosins and stress fibers. The restoration of
tropomyosin expression results in stress fibers and reduces
cell motility. These studies provide a direct causal link be-
tween TGF- regulation of stress fibers and control of cell
motility. These results suggest that the loss of the TGF-
stress fiber response in tumor cells is a critical step in pro-
metastatic conversion of the TGF- function.
We have investigated the mechanism of TGF- regulation
of actin filament dynamics and cell motility in normal and
tumor epithelial cells. In untransformed epithelial cells
TGF- can rapidly induce membrane ruffling and actin po-
lymerization at the cell edges, whereas a prolong incubation
with TGF- results in the formation of stable actin filament
bundles (stress fibers; Bakin et al., 2002; Edlund et al., 2002).
We found that inhibition of either de novo protein synthesis
or p38Mapk blocked TGF- induction of stress fibers, sug-
gesting that novel transcription/translation and p38Mapk
signaling are required for TGF-–mediated stress fiber for-
mation. Consistent with these findings expression of kinase-
inactive p38Mapk inhibited TGF- induction of actin stress
fibers (Bakin et al., 2002). Here we show that concomitantly
with stress fibers TGF- induced a sustained activation of
p38Mapk signaling and phosphorylation of HSP27 (Figure
3), a downstream target of the p38Mapk-MAPKAP kinase 2
pathway (Stokoe et al., 1992). Phosphorylated HSP27 and the
triple aspartate mutant mimicking HSP27 phosphorylation
at Ser15, Ser78, and Ser82 form small oligomers and tetram-
ers that facilitate de novo actin polymerization (Huot et al.,
1998; Hedges et al., 1999; Rogalla et al., 1999). We found that
although inhibition of de novo protein synthesis blocked
stress fibers, it did not affect p38Mapk signaling (Figure 1d),
suggesting that p38Mapk-HSP27 signaling is required but
not sufficient for TGF- induction of stress fibers. This no-
tion is also supported by previous studies that have sug-
gested involvement of Smad signaling in stress fiber forma-
tion (Piek et al., 1999a).
We identified several TGF- target genes including - and
-tropomyosins, -actinin1, and calponin2 encoding actin-
binding proteins implicated in the assembly of stress fibers.
Among these genes, tropomyosins (TMs) have been shown
to play a critical role in the stress fiber assembly by stabiliz-
ing actin filaments and preventing access of actin-severing
factors gelsolin and ADF/cofilin to filamentous actin (Paw-
lak and Helfman, 2001). We found that TGF- specifically
up-regulates expression of - and -TM genes encoding
high-molecular-weight TMs and does not regulate Tpm3
and Tpm4 genes encoding low-molecular-weight TMs (Ta-
ble 1). The expression of TMs correlated with the ability of
TGF- to induce stress fibers in several epithelial cell lines
including NMuMG, SiHa, and A549 cells. Moreover, sup-
pression of TM expression with siRNAs completely blocked
TGF- induction of stress fibers in mouse and human cell
lines, whereas ectopic expression of TM2 and TM3, products
of the -tropomyosin gene, was sufficient to induce stress
fibers even in the absence of the cytokine (Figures 6 and 7).
This is the first demonstration that TMs play an essential
role in TGF-–induced stress fiber formation in mouse and
human epithelial cell lines.
The TGF- induction of TM expression depends on
p38Mapk and Smad signaling. Inhibition of p38Mapk
blocked expression of TM proteins without a significant
effect on TM mRNA levels. These results suggest that
p38Mapk is involved in posttranscriptional control of TM
expression, although a recent study has implicated p38Mapk
in regulation of TM mRNA in intestinal epithelial cells
(Shields et al., 2002). Silencing of Smad4 with siRNAs sup-
pressed tropomyosin expression and blocked stress fiber
formation (Figure 4), whereas adenoviral expression of
Smad factors showed that Smad3 and Smad4 are required
for the induction of tropomyosins and formation of stress
fibers in epithelial cells (Figure 5). Importantly, inhibitory
Smad7, but not Smad6, blocks TGF- induction of TM ex-
pression and stress fiber formation. These results demon-
strate that Smad3/Smad4 and p38Mapk are required for
TGF-–induced TM expression and stress fiber formation in
epithelial cells.
Tropomyosins have been implicated in regulation of actin
filament dynamics and control of cell motility (Pawlak and
Helfman, 2001). Early studies have found that cell transfor-
mation by oncogenic Ras and Src leads to down-regulation
of tropomyosins and disruption of actin stress fiber fila-
ments (Leonardi et al., 1982; Hendricks and Weintraub,
1984). Subsequently, it has been shown that ectopic expres-
sion of tropomyosins in Ras-transformed fibroblasts restores
stress fibers and significantly reduces cell motility and cell
growth (Takenaga and Masuda, 1994; Braverman et al., 1996;
Gimona et al., 1996; Janssen and Mier, 1997). The importance
of tropomyosins in the control of tumor invasion and me-
tastasis is highlighted by several studies indicating that
high-grade tumors of breast, prostate, bladder, and brain
express significantly lower levels of tropomyosins that that
of normal tissues (Franzen et al., 1996; Wang et al., 1996;
Hughes et al., 2003; Raval et al., 2003). Thus, tropomyosins
and thereby stress fibers may play a critical role in the TGF-
control of tumor invasion and metastasis. In support of this
idea, we found that TGF- induction of tropomyosins and
stress fibers is markedly reduced in metastatic breast cancer
MDA-MB-231 cell line (Figure 7). MDA-MB-231 cells express
constitutively active Ras-ERK signaling (Kozma et al., 1987;
Ogata et al., 2001) that has been implicated in down-regula-
tion of tropomyosins and disruption of actin stress fibers
(Ljungdahl et al., 1998; Shields et al., 2002). We found that
pharmacological inhibition of the Raf-ERK pathway signif-
icantly increased basal and TGF-–induced levels of TM1,
restored TGF- induction of stress fibers, and inhibited cell
motility without any effect on phosphorylation of cofilin
(Figures 7 and 8). These results can be attributed at least in
part to changes in Smad signaling. In fact, recent studies
have shown that the Ras-ERK pathway attenuates Smad
signaling by affecting the subcellular localization of Smad2
and Smad3 (Kretzschmar et al., 1999) and by inducing a
proteasome-mediated degradation of Smad4 (Saha et al.,
2001). We also found that the -TM gene is not expressed in
MDA-MB-231 cells. Our unpublished data indicate that the
CpG island in the proximal promoter of the human -TM
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gene is methylated. The significance of this finding is cur-
rently under investigation. Importantly, ectopic expression
of TM3 in MDA-MB-231 cells resulted in stress fibers (Figure
8) and severely affected cell motility. This finding is consis-
tent with studies in rat NRK 1569 cells and mouse NIH-3T3
cells (Gimona et al., 1996; Janssen and Mier, 1997). Our
previous results suggest that Ras-ERK signaling does not
affect TGF- induction of membrane ruffling at the leading
edge (Bakin et al., 2002). Thus, Ras-ERK signaling suppresses
TGF- induction of tropomyosin expression and stress fibers
leading to more motile and invasive phenotype.
The Rho-like GTPases, RhoA, Rac1, and CDC42, have
been implicated in TGF- mediated stress fiber formation
(Moustakas and Stournaras, 1999; Bhowmick et al., 2001;
Bakin et al., 2002; Edlund et al., 2002). These GTPases
through RhoA-ROCK/Rho-kinase and Rac/CDC42-Pak sig-
naling can activate LIM kinases that negatively regulate
ADF/cofilins by phosphorylating a conserved Serine3 in
ADF/cofilins (Gungabissoon and Bamburg, 2003). ADF/
cofilins regulate the turnover rates of actin filaments by
promoting the dissociation of actin filaments into monomers
(Bamburg, 1999). Thus, Rho-like GTPases through LIM ki-
nases may contribute to stress fiber formation by inhibiting
actin depolymerization. In this study we found that phos-
phorylation of cofilin was not modulated by TGF- in three
different cell lines, suggesting that the ROCK/LIM-kinase/
cofilin pathway is not a target in TGF- induction of stress
fibers. Tropomyosins bound to filamentous actin prevent
access of ADF/cofilins to actin filaments, thereby stabilizing
actin filaments and reducing actin dynamics (Ono and Ono,
2002). In addition to tropomyosins, calponin2 and -acti-
nin1, two other TGF- targets identified in this study, have
been also implicated in stabilization of actin filaments (Pa-
nasenko and Gusev, 2001; Gimona et al., 2003). It remains to
be determined whether, in addition to tropomyosins, cal-
ponins and -actinin play a role in formation of stress fibers
in response to TGF- by blocking ADF/cofilins and gelsolin
from binding to actin filaments.
Our studies demonstrate an important role of tropomyo-
sins in TGF- regulation of stress fibers and cell migration
(Figure 9). ERK signaling may inhibit TGF- induction of
stress fibers by suppressing Smad-dependent expression of
tropomyosins. In addition, ERK signaling may affect stress
fibers by disabling the RhoA/ROCK pathway (Pawlak and
Helfman, 2002a, 2002b; Sahai et al., 2001; Vial et al., 2003).
The suppression of tropomyosin expression by oncogenic
Src (Hendricks and Weintraub, 1984) may also contribute to
the cooperation of TGF- and Src in tumorigenesis (Sieweke
et al., 1990). Thus, our study support an idea that the acqui-
sition of metastatic phenotype by tumor cells results from
the action of oncogenes and tumor suppressor genes regu-
lating cell proliferation and survival (Bernards and Wein-
berg, 2002). Our results suggest that loss of TGF- induction
of stress fibers is an essential characteristic of a prometastatic
conversion of TGF- function and restoration of this re-
sponse represents a potential target for the development of
effective antimetastatic therapies.
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